Pharmacokinetic-pharmacodynamic modeling of the anticancer effect of erlotinib in a human non-small cell lung cancer xenograft mouse model

AIM: Erlotinib is used to treat non-small-cell lung cancer (NSCLC), which targets epidermal growth factor receptor (EGFR) tyrosine kinase. The aim of this study was to investigate the relationship between erlotinib plasma concentrations and phosphorylated EGFR (pEGFR) levels, as well as the relation...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Wu, Qiong, Li, Meng-yao, Li, Han-qing, Deng, Chen-hui, Li, Liang, Zhou, Tian-yan, Lu, Wei
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2013
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4006468/
https://ncbi.nlm.nih.gov/pubmed/24096601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2013.101
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires